Medicine Description gliptus-plus 50/850 mg
GLIPTUS PLUS is a medication that combines metformin and vildagliptin, offering a synergistic approach to managing type 2 diabetes. Metformin primarily works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, thereby enhancing glucose uptake and reducing blood sugar levels. Vildagliptin, a DPP-4 inhibitor, enhances the levels of incretin hormones, which are responsible for increasing insulin secretion in response to meals and lowering glucagon levels. This dual mechanism not only stabilizes blood glucose levels throughout the day but also minimizes postprandial glucose spikes, thereby contributing to overall glycemic control and reducing the risk of diabetes-related complications.
Indications and Uses of GLIPTUS PLUS
- Management of type 2 diabetes mellitus in adults.
- Improving glycemic control in conjunction with diet and exercise.
- Supplementing other antidiabetic therapies when additional blood sugar control is necessary.
Side Effects of GLIPTUS PLUS
- Nausea and vomiting.
- Diarrhea.
- Abdominal pain.
- Flatulence.
- Hypoglycemia (particularly when combined with other antidiabetic agents).
- Skin reactions such as rash or itching.
Storage and Handling
Store GLIPTUS PLUS at room temperature, away from moisture and heat. Keep it in its original packaging to protect from light. Ensure it is out of reach of children.
Patient Advice and Precautions
Patients should adhere to prescribed dietary modifications and engage in regular physical activity to enhance the effectiveness of GLIPTUS PLUS. It is crucial to monitor blood sugar levels regularly and report any significant fluctuations or symptoms of hypoglycemia to a healthcare provider. Patients should also be informed about the potential for gastrointestinal side effects and to take the medication with food to minimize discomfort.